Erste Asset Management Gmb H Biotechnology

Erste Asset Management Gmb H

$8.15 Trillion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
LGND Ligand Pharmaceuticals Inc	$1.8B	$470 Million 0.01% of portfolio	4,300	Q2 2022 Reduced 40.28%
HRMY Harmony Biosciences Holdings, Inc.	$1.75B	$448 Million 0.01% of portfolio	13,100	Q3 2024 New
SWTX Spring Works Therapeutics, Inc.	$2.34B	$447 Million 0.01% of portfolio	12,300	Q3 2024 New
AUTL Autolus Therapeutics PLC	$122M	$441 Million 0.01% of portfolio	195,000	Q1 2023 Added 62.5%
IBRX Immunity Bio, Inc.	$1.16B	$425 Million 0.01% of portfolio	153,000	Q3 2024 New
ZLAB Zai Lab LTD	$3.09B	$402 Million 0.0% of portfolio	15,100	Q4 2021 Reduced 27.81%
GLPG Galapagos Nv	$1.59B	$382 Million 0.0% of portfolio	14,000	Q1 2022 Sold Out
EYPT Eye Point Pharmaceuticals, Inc.	$195M	$360 Million 0.0% of portfolio	50,000	Q4 2024 New
KROS Keros Therapeutics, Inc.	$328M	$340 Million 0.0% of portfolio	20,700	Q3 2022 Reduced 72.46%
BCRX Biocryst Pharmaceuticals Inc	$1.31B	$308 Million 0.0% of portfolio	40,000	Q3 2024 New
NTLA Intellia Therapeutics, Inc.	$570M	$265 Million 0.0% of portfolio	22,100	Q1 2023 Reduced 0.2%
IOVA Iovance Biotherapeutics, Inc.	$538M	$251 Million 0.0% of portfolio	34,000	Q4 2021 Added 88.24%
RXRX Recursion Pharmaceuticals, Inc.	$994M	$248 Million 0.0% of portfolio	33,500	Q3 2024 New
ADPT Adaptive Biotechnologies Corp	$1.12B	$225 Million 0.0% of portfolio	35,700	Q4 2020 Reduced 15.0%
VIR Vir Biotechnology, Inc.	$739M	$215 Million 0.0% of portfolio	28,800	Q4 2021 Added 15.63%
BCYC Bicycle Therapeutics PLC	$210M	$204 Million 0.0% of portfolio	14,000	Q3 2024 New
ABCL Ab Cellera Biologics Inc.	$696M	$185 Million 0.0% of portfolio	62,000	Q3 2024 New
SAGE Sage Therapeutics, Inc.	$440M	$158 Million 0.0% of portfolio	28,500	Q2 2022 Reduced 19.72%
MRVI Maravai Lifesciences Holdings, Inc.	$233M	$156 Million 0.0% of portfolio	28,400	Q3 2024 New
REPL Replimune Group, Inc.	$370M	$146 Million 0.0% of portfolio	11,900	Q3 2024 New
RLAY Relay Therapeutics, Inc.	$309M	$101 Million 0.0% of portfolio	23,100	Q3 2024 New
RGNX Regenxbio Inc.	$274M	$96.3 Million 0.0% of portfolio	13,000	Q3 2024 New
ALLO Allogene Therapeutics, Inc.	$206M	$68.8 Million 0.0% of portfolio	31,400	Q4 2021 Added 29.94%
SANA Sana Biotechnology, Inc.	$344M	$64.4 Million 0.0% of portfolio	40,000	Q3 2024 New
ALEC Alector, Inc.	$80.9M	$33.8 Million 0.0% of portfolio	19,000	Q3 2024 New
MRNA Moderna, Inc.	$10.5B	$0 0.0% of portfolio	0	Q4 2024 New
TECH Bio Techne Corp	$2.06B	$0 0.0% of portfolio	0	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.